-
2008
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
-
Product Pipeline
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
ZP1848 Publications
Petersen, Y.M., Clausen, T.S., Kjølbye, A., Ørskov, A., Petersen, J.S. Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Annual meeting - Pharmacology of Membrane Proteins: from molecule to clinic. Joint meeting between The German Pharmacological Society and The Danish Society of Pharmacology and Toxicology, 21-22 June 2007, Copenhagen, Denmark
Poster Abstract No. 20, Meeting Programme p 41
Poster
Petersen. Y.M., Clausen, T.S., Kjølbye, A., Ørskov, C., Petersen, J.S., Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Poster abstract for 14th United European Gastroenterology Week (UEGW 2006), 21-25 October 2006, Berlin, Germany. Poster MON-G-247
Gut, 2006, 55, Supplement No. V, A130
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.